Redmile Group’s Regenxbio RGNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.2M | Sell |
|
|||||
|
2025
Q1 | $34.3M | Hold |
|
|||||
|
2024
Q4 | $37.1M | Sell |
|
|||||
|
2024
Q3 | $51.3M | Buy |
|
|||||
|
2024
Q2 | $53.5M | Buy |
|
|||||
|
2024
Q1 | $95.9M | Buy |
|
|||||
|
2023
Q4 | $67.5M | Buy |
|
|||||
|
2023
Q3 | $42.4M | Buy |
|
|||||
|
2023
Q2 | $40.5M | Buy |
|
|||||
|
2023
Q1 | $31M | Sell |
|
|||||
|
2022
Q4 | $43.4M | Sell |
|
|||||
|
2022
Q3 | $50.7M | Sell |
|
|||||
|
2022
Q2 | $49.5M | Buy |
|
|||||
|
2022
Q1 | $65.6M | Buy |
|
|||||
|
2021
Q4 | $62M | Sell |
|
|||||
|
2021
Q3 | $84.2M | Sell |
|
|||||
|
2021
Q2 | $83.1M | Sell |
|
|||||
|
2021
Q1 | $79.8M | Buy |
|
|||||
|
2020
Q4 | $96.3M | Sell |
|
|||||
|
2020
Q3 | $61.3M | Sell |
|
|||||
|
2020
Q2 | $82.4M | Sell |
|
|||||
|
2020
Q1 | $75.7M | Sell |
|
|||||
|
2019
Q4 | $103M | Buy |
|
|||||
|
2019
Q3 | $84.1M | Buy |
|
|||||
|
2019
Q2 | $71.5M | Sell |
|
|||||
|
2019
Q1 | $81.4M | Buy |
|
|||||
|
2018
Q4 | $56.8M | Sell |
|
|||||
|
2018
Q3 | $125M | Buy |
|
|||||
|
2018
Q2 | $112M | Sell |
|
|||||
|
2018
Q1 | $63.6M | Buy |
|
|||||
|
2017
Q4 | $47.4M | Sell |
|
|||||
|
2017
Q3 | $55M | Sell |
|
|||||
|
2017
Q2 | $33.9M | Buy |
|
|||||
|
2017
Q1 | $24.5M | Buy |
|
|||||
|
2015
Q4 | – | Sell |
|
|||||
|
2015
Q3 | $6.1M | Buy |
|